DNAG OTC
DNAPrint Genomics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: +100.0%
3Y: -80.0%
5Y: +100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$6M
-60.3% ▼
Capital Expenditures
$391K
-216.7% ▼
5Y CAGR: +21.9%
Free Cash Flow
-$6M
-65.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$1M
-246.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2002 | FY2003 | FY2004 | FY2005 | FY2006 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$8M | -$4M | -$9M | -$12M |
| Depreciation & Amort. | $449K | $1M | $1M | $877K | $1M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $405K | $85K | -$1M | $585K | $2M |
| Other Non-Cash Items | $688K | $5M | $27K | $4M | $4M |
| Operating Cash Flow | -$2M | -$2M | -$4M | -$4M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$16K | -$14K | -$57K | -$124K | -$391K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $555K |
| Investment Purchases | $0 | $0 | $0 | -$2M | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $10K | $0 | -$194K | $202K | $0 |
| Investing Cash Flow | -$6K | -$14K | -$251K | -$2M | $163K |
| — Financing Activities — | |||||
| Net Debt Issuance | $1M | $653K | -$149K | $2M | $1M |
| Stock Repurchased | $0 | $0 | $0 | -$135K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $85K | $238K | $255K | $0 | $0 |
| Financing Cash Flow | $2M | $2M | $5M | $7M | $4M |
| Net Change in Cash | -$31K | $254K | $713K | $828K | -$1M |
| Cash End of Period | $12K | $266K | $979K | $2M | $595K |
| Free Cash Flow | -$2M | -$2M | -$4M | -$4M | -$6M |